Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Driver gene mutations and clinical features predict bone metastasis risk in NSCLC: a logistic regression model.

Cancer genetics - 1 Jun 2026

Gou Haimei, He Shuang, Cheng Jiao, Yang Hui, Zhong Xiaowu

Abstract excerpt

Bone metastasis affects approximately 40% of patients with non-small cell lung cancer (NSCLC), significantly impacting patient survival and prognosis. However, the molecular mechanisms linking driver gene mutations to bone metastasis remain poorly understood. This study retrospectively analyzed 362 East Asian population patients with NSCLC to investigate the association and to construct a prediction model based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Bone Neoplasms
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Logistic Models

Share to Lung Neoplasms

Share to Prognosis

Share to Risk Factors

Source

Identifiers

PMID: 41780368
DOI: 10.1016/j.cancergen.2026.02.006

Genes

EGFR
ALK
KRAS

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Driver gene mutations and clinical features predict bone metastasis risk in NSCLC: a logistic regression model.PMID 41780368Read ↗

Assessing EGFR-mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy.Semantic proximity Read ↗

[Impact of bone metastasis on the prognosis of lung adenocarcinoma patients treated with third-generation EGFR-TKI and the underlying mechanisms].Semantic proximity Read ↗

Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.Semantic proximity Read ↗

Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer.Semantic proximity Read ↗

Screening of gene mutations associated with bone metastasis in nonsmall cell lung cancer.Semantic proximity Read ↗

Association of mutation profiles with metastasis in patients with non-small cell lung cancerSemantic proximity Read ↗

Advances in Lung Cancer Driver Genes Associated With Brain MetastasisSemantic proximity Read ↗

Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.Semantic proximity Read ↗

Prognostic Risk Factors for Cancer-Specific Bone Metastasis: A Registry-Based Analysis of 13,742 PatientsSemantic proximity Read ↗

Evaluation of the prognostic value of the new 9th edition Tumor-Node-Metastases (TNM) staging system for epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma patients with bone metastases.Semantic proximity Read ↗

Mutational characteristics of bone metastasis of lung cancer.Semantic proximity Read ↗

Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer: a retrospective, multicenter studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.